☆ 4.5 Article

NDRG3 regulates imatinib resistance by promoting β-catenin accumulation in the nucleus in chronic myelogenous leukemia

ONCOLOGY REPORTS (2023)

Related references

Note: Only part of the references are listed.

Review Hematology

Radiation and leukaemia: Which leukaemias and what doses?

Robert Peter Gale

Summary: The cause of most cases of leukaemia is unknown, but exposures to ionizing radiations, certain chemicals, and anti-cancer drugs have been identified as possible causes. Evidence from various sources suggests that ionizing radiations can cause different types of leukaemia, with some types being more sensitive to induction than others. The mechanism by which ionizing radiations cause leukaemia varies for different types. The localization of haemopoietic stem cells in the bone marrow is a topic of discussion.

BLOOD REVIEWS (2023)

Add to Collection

Article Medicine, General & Internal

MiR-25 enhances autophagy and promotes sorafenib resistance of hepatocellular carcinoma via targeting FBXW7

Xiaoning Feng et al.

Summary: MiR-25 increases sorafenib resistance of HCC cells by inducing autophagy and is associated with tumor pathological grade, clinic staging, and lymphatic metastasis, making it a potential novel therapeutic target for HCC treatment.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2022)

Add to Collection

Article Health Care Sciences & Services

MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition

Xifeng Sun et al.

Summary: This study revealed the upregulation of miR-483 in colorectal cancer and its prediction of poor prognosis through promoting cell proliferation and invasion. NDRG2 was identified as the target gene of miR-483, and the miR-483/PI3K/AKT pathway and EMT were shown to be involved in cell proliferation and invasion. These findings suggest that miR-483 could be a potential therapeutic target for preventing colorectal cancer.

JOURNAL OF HEALTHCARE ENGINEERING (2022)

Add to Collection

Review Hematology

How I treat chronic-phase chronic myelogenous leukemia

Ellin Berman

Summary: The introduction of imatinib, the first tyrosine kinase inhibitor (TKI) for chronic myelogenous leukemia (CML), revolutionized the treatment of this disease. Subsequent generations of TKIs, such as dasatinib, nilotinib, bosutinib, and ponatinib, have further improved treatment outcomes. Individualized TKI therapy has provided options for patients who do not respond to or cannot tolerate first-line treatment, leading to a significant decrease in the number of patients progressing to advanced stages of the disease. This article reviews newer aspects of clinical care in CML, including the use of bosutinib and asciminib, the cardiac safety of ponatinib, and the consideration of family planning and treatment discontinuation.

BLOOD (2022)

Add to Collection

Article Medicine, Research & Experimental

The role of microRNAs in the development, progression and drug resistance of chronic myeloid leukemia and their potential clinical significance

Abbas Navabi et al.

Summary: This review summarizes the roles of miRNAs in the development, progression, and drug resistance of CML, as well as their potential role in the diagnosis, prognosis, and treatment response of CML.

LIFE SCIENCES (2022)

Add to Collection

Article Cell Biology

Glycogen Storage Disease Phenotypes Accompanying the Perturbation of the Methionine Cycle in NDRG3-Deficient Mouse Livers

Hyun Ahm Sohn et al.

Summary: NDRG3 plays an important role in the regulation of liver cell metabolism, and its loss of function leads to excessive glycogen accumulation, hypoglycemia, elevated liver triglyceride content, and perturbation of the methionine cycle. These findings suggest therapeutic potential for regulating NDRG3 in disorders related to metabolic pathways.

CELLS (2022)

Add to Collection

Article Oncology

Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy

Yu-Feng Xiao et al.

Summary: This study found that lncSLCO1C1 is highly expressed in gastric carcinoma (GC) tissue samples and is associated with poor overall survival in patients. lncSLCO1C1 promotes cell proliferation and migration in GC, as well as conferring resistance to oxaliplatin chemotherapy. It acts as a scaffold for the SSRP1/H2A/H2B complex and absorbs miR-211-5p and miR-204-5p, leading to increased expression of SSRP1. The findings highlight the role of lncSLCO1C1 in GC progression.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Oncology

Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type-B receptor 4

Weina Ma et al.

Summary: EPHB4 plays an oncogenic role in CML, as its knockdown inhibits cell growth and increases sensitivity to imatinib. Vandetanib, by targeting EPHB4, shows potential in inhibiting CML growth and overcoming imatinib resistance.

MOLECULAR ONCOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

KIF23 promotes autophagy-induced imatinib resistance in chronic myeloid leukaemia through activating Wnt/β-catenin pathway

Yong Huang et al.

Summary: KIF23 is involved in autophagy and contributes to imatinib resistance in chronic myeloid leukaemia (CML) through activation of the Wnt/beta-catenin pathway.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2022)

Add to Collection

Article Cell Biology

Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1

Fanting Zeng et al.

Summary: Wee1 plays a crucial role in the treatment of CML by regulating DNA damage repair. Inhibiting Wee1 can improve the sensitivity to Imatinib and inhibit cancer cell proliferation.

CELL COMMUNICATION AND SIGNALING (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Jiaqi Liu et al.

Summary: This article provides a comprehensive review of the Wnt/β-catenin pathway, including its origin, composition, function, and clinical trials. It also discusses the challenges and opportunities for developing small-molecule compounds targeting this signaling pathway in disease treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Add to Collection

Review Urology & Nephrology

WNT-β-catenin signalling - a versatile player in kidney injury and repair

Stefan J. Schunk et al.

Summary: The WNT-beta-catenin pathway plays a critical role in kidney development and repair, with transient activation aiding in tissue regeneration after acute kidney injury, but uncontrolled signalling can lead to kidney fibrosis and other kidney diseases.

NATURE REVIEWS NEPHROLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation

Lihong Ding et al.

Summary: Constitutively activated BCR-ABL kinase is the driver event in chronic myeloid leukemia (CML) development. Imatinib, the first BCR-ABL inhibitor, has improved clinical outcomes, but resistance occurs in 25-30% of patients. Simvastatin, a HMG-CoA reductase inhibitor, shows antitumor effects and acts as a sensitizer to kill imatinib-resistant and T315I mutated CML cells.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Add to Collection

Review Chemistry, Medicinal

Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives

Zhen Wang et al.

Summary: Aberrant activation of the Wnt/beta-catenin signaling pathway is associated with cancer, and direct targeting of beta-catenin is a promising strategy but challenging. Research has identified potential small-molecule binding sites and summarized bioactive small molecules that target beta-catenin directly.

MEDICINAL RESEARCH REVIEWS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Proteome dynamics at broken replication forks reveal a distinct ATM-directed repair response suppressing DNA double-strand break ubiquitination

Kyosuke Nakamura et al.

Summary: Cells have evolved an elaborate DNA repair network to ensure accurate and complete DNA replication, with defects in these mechanisms potentially leading to genome instability and therapeutic vulnerabilities. Research shows that ATM signaling stimulates DNA end resection, recruits PLK1, and suppresses the canonical DSB ubiquitination response, providing new insights into how cells orchestrate homologous recombination repair of replication-associated DSBs.

MOLECULAR CELL (2021)

Add to Collection

Review Cell Biology

Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future

Valentina R. Minciacchi et al.

Summary: The article chronicles the journey of chronic myeloid leukemia, focusing on molecular pathways and treatment strategies aimed at eradicating leukemia stem cells.

CELLS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The LINC01410/miR-122-5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells

Weiguo Ma et al.

Summary: Our study revealed that LINC01410 is overexpressed in OS tissues and promotes cell proliferation and migration. We also found that LINC01410 binds to miR-122-5p, and miR-122-5p binds to NDRG3. Knockdown of LINC01410 inhibited the proliferation, invasion, and migration of OS cells.

IUBMB LIFE (2021)

Add to Collection

Article Multidisciplinary Sciences

Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2

Abhishek Sinha et al.

Summary: SOX9 promotes turnover of β-catenin independently of the destruction complex and proteasome in mammalian cell culture. This requires the activation of MAML2, which acts as a coactivator for SOX9 in antagonizing the Wnt/β-catenin pathway. This newly identified pathway provides a parallel mechanism for restricting Wnt/β-catenin signaling.

SCIENCE ADVANCES (2021)

Add to Collection

Review Cell Biology

miRNA interplay: mechanisms and consequences in cancer

Meredith Hill et al.

Summary: miRNAs can control mRNA expression and target non-coding RNAs, including long non-coding RNAs and other miRNAs. MiRNA:miRNA interaction is a form of self-regulation, with direct, indirect, and global interactions being the main modes. Understanding the self-regulation of miRNAs can help identify novel regulatory mechanisms associated with disease pathways.

DISEASE MODELS & MECHANISMS (2021)

Add to Collection

Article Cell Biology

Shc3 promotes hepatocellular carcinoma stemness and drug resistance by interacting with β-catenin to inhibit its ubiquitin degradation pathway

Yun Liu et al.

Summary: High expression of Shc3 was observed in patients with chemoresistant and recurrent HCCs. Shc3 overexpression increased MDR1/P-glycoprotein expression and reduced HCC cell sensitivity to doxorubicin and sorafenib. This study suggests a potential strategy to target the Shc3 pathway in conjunction with systemic chemotherapy for improved clinical treatment of HCC.

CELL DEATH & DISEASE (2021)

Add to Collection

Article Cell Biology

Propofol Regulates the TLR4/NF-κB Pathway Through miRNA-155 to Protect Colorectal Cancer Intestinal Barrier

Yuhua Gao et al.

Summary: Propofol can protect the intestinal barrier, inhibit bacterial invasion, and increase beneficial bacteria levels. It inhibits the activation of the NF-kappa B pathway by downregulating miR-155 expression, thus reducing inflammatory cytokine secretion.

INFLAMMATION (2021)

Add to Collection

Article Toxicology

Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century

Mousumi Saha et al.

Summary: Overuse of antibiotics has led to the emergence of multidrug resistance as a potential global threat, emphasizing the urgent need for molecular analysis of resistance genes and mechanisms. Attention to the interaction of bacterial infections with COVID-19 is crucial in the current scenario to raise awareness of this critical situation.

JOURNAL OF XENOBIOTICS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Wnt/β-catenin signaling in cancers and targeted therapies

Fanyuan Yu et al.

Summary: Wnt/β-catenin signaling plays a critical role in human cancers, associated with cancer progression, prognosis, and mortality. Despite the development of therapies targeting this pathway, there are challenges in translating them into clinical practice.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Structural and Biophysical Analyses of Human N-Myc Downstream-Regulated Gene 3 (NDRG3) Protein

Kyung Rok Kim et al.

BIOMOLECULES (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The long non-coding RNA LOC285758 promotes invasion of acute myeloid leukemia cells by down-regulating miR-204-5p

Fangfang Xue et al.

FEBS OPEN BIO (2020)

Add to Collection

Article Oncology

Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance

Surui Yao et al.

CANCER MEDICINE (2020)

Add to Collection

Article Pharmacology & Pharmacy

Emodin Inhibits Resistance to Imatinib by Downregulation of Bcr-Abl and STAT5 and Allosteric Inhibition in Chronic Myeloid Leukemia Cells

Xin-Yi Wang et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2020)

Add to Collection

Article Medicine, Research & Experimental

A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells

Bailin He et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Review Oncology

Chronic myeloid leukemia stem cells

Mohammad Houshmand et al.

LEUKEMIA (2019)

Add to Collection

Article Medicine, General & Internal

Soluble fibre supplementation with and without a probiotic in adults with asthma: A 7-day randomised, double blind, three way cross-over trial

Rebecca McLoughlin et al.

EBIOMEDICINE (2019)

Add to Collection

Article Oncology

The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia

Susanna Grassi et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection

Review Hematology

New approaches to molecular monitoring in CML (and other diseases)

Jerald Radich et al.

BLOOD (2019)

Add to Collection

Review Genetics & Heredity

Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system

Simone L. Schonkeren et al.

NEUROGENETICS (2019)

Add to Collection

Review Gastroenterology & Hepatology

Wnt-β-catenin signalling in liver development, health and disease

Maria J. Perugorria et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Characterization of the prognostic values of the NDRG family in gastric cancer

Chaoran Yu et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

High NDRG3 expression facilitates HCC metastasis by promoting nuclear translocation of β-catenin

JiKui Shi et al.

BMB REPORTS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Is beta-Catenin a Druggable Target for Cancer Therapy?

Can Cui et al.

TRENDS IN BIOCHEMICAL SCIENCES (2018)

Add to Collection

Article Biotechnology & Applied Microbiology

NDRG3 facilitates colorectal cancer metastasis through activating Src phosphorylation

Ting Li et al.

ONCOTARGETS AND THERAPY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

VHL and Hypoxia Signaling: Beyond HIF in Cancer

Jing Zhang et al.

BIOMEDICINES (2018)

Add to Collection

Article Oncology

miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma

Marta Diaz-Martinez et al.

CANCER RESEARCH (2018)

Add to Collection

Article Biochemistry & Molecular Biology

A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance

Wengong Si et al.

CELL DEATH AND DIFFERENTIATION (2018)

Add to Collection

Article Biochemistry & Molecular Biology

Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution

Hye Shin Lee et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Add to Collection

Article Biochemical Research Methods

7-Ketocholesterol overcomes drug resistance in chronic myeloid leukemia cell lines beyond MDRI mechanism

Livia Rosa Fernandes et al.

JOURNAL OF PROTEOMICS (2017)

Add to Collection

Article Oncology

MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance

Zhonghai Du et al.

CANCER BIOMARKERS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

miR-204-5p targeting SIRT1 regulates hepatocellular carcinoma progression

Guangbin Jiang et al.

CELL BIOCHEMISTRY AND FUNCTION (2016)

Add to Collection

Article Gastroenterology & Hepatology

Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis

Xiaofang Sun et al.

HEPATOLOGY (2016)

Add to Collection

Article Pathology

High expression of NDRG3 associates with positive lymph node metastasis and unfavourable overall survival in laryngeal squamous cell carcinoma

Jun Ma et al.

PATHOLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

NDRG3-mediated lactate signaling in hypoxia

Kyung Chan Park et al.

BMB REPORTS (2015)

Add to Collection

Article Oncology

Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment

Oshrat Hershkovitz-Rokah et al.

CANCER LETTERS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

A Lactate-Induced Response to Hypoxia

Dong Chul Lee et al.

CELL (2015)

Add to Collection

Article Biochemical Research Methods

Augmentation of multiple protein kinase activities associated with secondary imatinib resistance in gastrointestinal stromal tumors as revealed by quantitative phosphoproteome analysis

Kayoko Nagata et al.

JOURNAL OF PROTEOMICS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia

C. Xu et al.

ONCOGENE (2014)

Add to Collection

Review Biochemistry & Molecular Biology

The many faces and functions of β-catenin

Tomas Valenta et al.

EMBO JOURNAL (2012)

Add to Collection

Review Cell Biology

Wnt signaling and skeletal development

Fei Liu et al.

CELLULAR SIGNALLING (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.